All Stories

  1. Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma
  2. T cell Bim is a marker for cancer patient's responses to anti-PD-1 immunotherapy
  3. PD-L1 antibody may impair T cell function
  4. T cell Bim levels reflect responses to anti–PD-1 cancer therapy
  5. CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1
  6. B7-H1 signaling is integrated during CD8+ T cell priming and restrains effector differentiation
  7. Markers to identify human tumor-reactive T cells
  8. B7-H1 limits the entry of effector CD8+T cells to the memory pool by upregulating Bim
  9. Soluble B7-H1: Differences in production between dendritic cells and T cells
  10. B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes
  11. B7-H1 pathway and its role in the evasion of tumor immunity
  12. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
  13. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
  14. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion